GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Glucose Health, Inc.
Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)
Close on Oct 19, 2026
- Market cap
- $1.82M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.4048 (+1,153%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Glucose Health, Inc. saw revenue fall 70.6% to $88.13K over the twelve months to Sep 30, 2017.
Revenue
$88.13K
-70.6% vs. a year earlier
Operating income
-$32.45K
TTM Q3 2017
EPS, diluted
-$0.04
TTM Q3 2017
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2017
Valuation
- Market cap
- $1.82M
- P/E ratio
- –
- Price to sales
- 20.71
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $88.13K
- Net income
- -$85.06K
- EPS, diluted
- -$0.04
- Book value per share
- -$0.10
- Diluted shares
- 4M
Eight years at a glance
Fiscal years 2009 to 2016 and trailing twelve months, USD
Revenue
$88.13K-70.6% YoY
Gross profit
$57.63K+205.9% YoY
Operating income
-$32.45K
Net income
-$85.06K
EPS, diluted
-$0.04
Reported periodTrailing twelve months